Grace Therapeutics GRCE
NASDAQ GRCE
$1.75 -0.06 (-3.31%)
At close: Nov 16, 2026 · 4:00 PM EST

Grace Therapeutics (GRCE) Enterprise Value (2012 - 2026)

Updated

Grace Therapeutics (GRCE) posted Enterprise Value of $21.94 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), down 13.1% from $25.24 million a year earlier and down 5.4% from the prior quarter.

Analysis

Grace Therapeutics (GRCE) Enterprise Value (2012 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Enterprise Value at Grace Therapeutics was -$27.46 million; for FY2026 (ended Mar 31, 2026), it was $57.21 million, up 525.7% from FY2025.

  • Annual Enterprise Value shows a five-year compound annual growth rate of 40.4% (FY2021 to FY2026).
  • In prior fiscal years, Grace Therapeutics' Enterprise Value was $9.14 million in FY2025 (-1.0%), $9.23 million in FY2024, -$7.37 million in FY2023 and $1.29 million in FY2022 (-87.7%).
  • The fiscal Q2 2027 figure stands as the lowest quarterly Enterprise Value since fiscal Q4 2025.
  • On a year-over-year basis, Enterprise Value increased in four of the last seven quarters, with growth averaging 121.4%.
  • The strongest year-over-year quarter for Enterprise Value in the past five years was fiscal Q4 2026, with growth of 525.7%; the weakest was fiscal Q4 2022, with a decline of 87.7%.
  • According to Business Quant data, Enterprise Value for the three prior fiscal quarters was $23.19 million (Q1 2027), $57.21 million (Q4 2026) and $34.87 million (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn
10 Grace Therapeutics 35.10 Mn -35.61 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 21.94 Mn
Jun 30, 2026 23.19 Mn
Mar 31, 2026 57.21 Mn
Dec 31, 2025 34.87 Mn
Sep 30, 2025 25.24 Mn
Jun 30, 2025 39.15 Mn
Mar 31, 2025 9.14 Mn
Dec 31, 2024 26.87 Mn
Sep 30, 2024 15.25 Mn
Jun 30, 2024 10.20 Mn
Mar 31, 2024 9.23 Mn
Dec 31, 2023 2.05 Mn
Sep 30, 2023 -6.01 Mn
Jun 30, 2023 2.00 Mn
Mar 31, 2023 -7.37 Mn
Dec 31, 2022 -8.95 Mn
Sep 30, 2022 -9.06 Mn
Jun 30, 2022 -127,230.61
Mar 31, 2022 1.29 Mn
Dec 31, 2021 9.48 Mn
API Access

Grace Therapeutics Enterprise Value API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=enterprise-value&ticker=GRCE&period=max&api_key=YOUR_API_KEY